| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 06/29/2005 | EP1548029A2 Peptid- and peptide mimetic derivatives having integrin inhibitor properties III |
| 06/29/2005 | EP1548028A1 Substituted type peptides of wt1 |
| 06/29/2005 | EP1548027A1 Compound binding to leukocytes and medicinal composition containing the compound in labeled state as the active ingredient |
| 06/29/2005 | EP1546719A2 Isolation and identification of t cells |
| 06/29/2005 | EP1546717A1 Analyzing nerve cell damage |
| 06/29/2005 | EP1546714A1 Compositions and methods of use of targeting peptides for diagnosis and therapy of human cancer |
| 06/29/2005 | EP1545610A2 Epitope sequences |
| 06/29/2005 | EP1545595A2 Modified transferrin fusion proteins comprising duplicate transferrin amino or carboxy terminal domains |
| 06/29/2005 | EP1545581A1 Peptides and related molecules that modulate nerve growth factor activity |
| 06/29/2005 | EP1545580A2 New therapeutic uses of tri-, tetra-, penta-, and polypeptides |
| 06/29/2005 | EP1545572A2 Conjugates activated by cell surface proteases and therapeutic uses thereof |
| 06/29/2005 | EP1545556A2 Nucleic acid and corresponding protein entitled 98p4b6 useful in treatment and detection of cancer |
| 06/29/2005 | EP1272507B1 Integrin binding peptide derivatives |
| 06/29/2005 | EP1268497B1 Ternary ligand complexes useful as radiopharmaceuticals |
| 06/29/2005 | EP0929574B1 MODULATORS OF beta-AMYLOID PEPTIDE AGGREGATION COMPRISING D-AMINO ACIDS |
| 06/29/2005 | CN1633446A Novel peptides as NS3-serine protease inhibitors of hepatitis C virus |
| 06/29/2005 | CN1633289A Hemiasterlin derivatives and uses thereof |
| 06/28/2005 | US6911526 Compounds that inhibit the interaction between signal-transducing proteins and the GLGF (PDZ/DHR) domain and uses thereof |
| 06/28/2005 | US6911525 Lipopeptides as antibacterial agents |
| 06/28/2005 | US6911428 Diaryl peptides as NS3-serine protease inhibitors of hepatitis C virus |
| 06/28/2005 | US6911426 Inhibitor of apoptosis proteins (IAP); survivin |
| 06/28/2005 | US6911309 Nucleic acids encoding MTAse |
| 06/28/2005 | US6911206 Fusion proteins comprising carriers that can induce a dual immune response |
| 06/23/2005 | WO2005056594A1 Akt ACTIVITY SPECIFICALLY INHIBITING POLYPEPTIDE |
| 06/23/2005 | WO2005056581A2 Peptide able to specifically bind a chemokine receptor and use thereof |
| 06/23/2005 | WO2005056577A2 Peptide inhibitors of hiv |
| 06/23/2005 | WO2005056576A2 Branched peptide amphiphiles, related epitope compounds and self assembled structures thereof |
| 06/23/2005 | WO2005056043A2 Use of enzymatic inhibitors of h-prune for the prevention and treatment of the metastases of tumours overexpressing h-prune |
| 06/23/2005 | WO2005056039A1 Self-assembling peptide amphiphiles and related methods for growth factor delivery |
| 06/23/2005 | WO2004018997A3 Methods and compositions for modulating amyloid beta |
| 06/23/2005 | US20050137329 homodimers of peptide monomers: (AcG)GLYACHMGPIT(1-nal)VCQPLR(MeG)0-1(K)0-1 each containing an intramolecular disulfide bond; spacer N1H (CH2)4 C4H N2H N1 in which N1 is covalently attached via a carbamate or an amide linkage to activated polyethylene glycol moiety; red blood cell production disorders |
| 06/23/2005 | US20050137140 Peptidomimetic compounds, useful as antiviral agents |
| 06/23/2005 | US20050137139 Peptidomimetic compounds, useful as antiviral agents; used to inhibit HCV replication and to lessen the risk of or the severity of HCV infection |
| 06/23/2005 | US20050137137 Inhibitors of the Interaction between p53 and MDM2 |
| 06/23/2005 | US20050137136 amino acid sequences which bind to gramnegative bacteria with high specificity, used for identification, detection, and isolation of bacteria, and for the delivery of nucleotides, proteins, toxins, liposomes and drugs to bacteria |
| 06/23/2005 | US20050137135 Novel analogues of glucose-dependent insulinotropic polypeptide |
| 06/23/2005 | US20050137133 nonimmunogenic water soluble polypeptides coupled to hydrophilic polymers, used as thrombopoietin agonist for the treatment of thrombocytopenia; blood disorders |
| 06/23/2005 | US20050137128 Modulators of ß-amyloid peptide aggregation |
| 06/23/2005 | US20050136454 Cell-signaling assays |
| 06/23/2005 | DE10355559A1 Transskin Transskin |
| 06/23/2005 | DE10354403A1 Gegen das Prothrombin-Fragment F 1+2 gerichtete Antikörper, ihre Herstellung und Verwendung Against the prothrombin fragment 1 + F 2 directed antibody, their preparation and use |
| 06/23/2005 | CA2549391A1 Branched peptide amphiphiles, related epitope compounds and self assembled structures thereof |
| 06/23/2005 | CA2549291A1 Use of enzymatic inhibitors of h-prune for the prevention and treatment of the metastases of tumours overexpressing h-prune |
| 06/23/2005 | CA2549164A1 Self-assembling peptide amphiphiles and related methods for growth factor delivery |
| 06/22/2005 | EP1543166A2 Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome |
| 06/22/2005 | EP1543142A1 Production method for iturin a and its homologues |
| 06/22/2005 | EP1543023A2 Secondary binding site of dipeptidyl peptidase iv (dp iv) |
| 06/22/2005 | EP1542733A2 Improved method to identify targeting molecules |
| 06/22/2005 | EP1542730A1 Modified therapeutic agents |
| 06/22/2005 | EP1542725A2 Method of humanizing immune system molecules |
| 06/22/2005 | EP1542716A1 Growth hormone releasing peptides |
| 06/22/2005 | EP1542711A2 PEPTIDES AS SOLUBILIZING EXCIPIENTS FOR TRANSFORMING GROWTH FACTOR s PROTEINS |
| 06/22/2005 | EP1542709A2 Peptide aggregates |
| 06/22/2005 | EP1244693B1 Compositions for treating abnormalities in glomerular filtration, patent ductus arteriosus and osteoporosis |
| 06/22/2005 | CN1630709A Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions |
| 06/21/2005 | US6909000 Inhibiting particularly the activity of hepatitis C virus NS3-NS4A protease; peptidomimetics having a bridged bicyclic moiety at the P2 position. |
| 06/21/2005 | CA2145749C Thrombin activatable plasminogen derivatives |
| 06/19/2005 | CA2494572A1 Cytochrome p450 24 (cyp24) monoclonal antibody and methods and uses thereof |
| 06/16/2005 | WO2005054427A2 Target sequences for synthetic molecules |
| 06/16/2005 | WO2005054293A1 Rgd targeting moiety its porduction and use |
| 06/16/2005 | WO2005054279A1 Delivery peptides, their constructs with active agents and use |
| 06/16/2005 | WO2005023861A3 Gdnf-related neuropeptides |
| 06/16/2005 | WO2005000878A3 Compositions of lipopeptide antibiotic derivatives and methods of use thereof |
| 06/16/2005 | WO2004111192A3 Targeted delivery to legumain-expressing cells |
| 06/16/2005 | WO2004101742A3 Protease inhibitors for coronaviruses and sars-cov and the use thereof |
| 06/16/2005 | WO2004094471A3 Mediators of reverse cholesterol transport for the treatment of hypercholesterolemia |
| 06/16/2005 | WO2004078779A3 Conopeptides and methods of use |
| 06/16/2005 | WO2004065557A3 PEPTIDE APTAMERS THAT BIND TO THE REP PROTEINS OF ssDNA VIRUSES |
| 06/16/2005 | WO2000053621A3 Synthetic complementary peptides and ophthalmologic uses thereof |
| 06/16/2005 | US20050130903 Therapeutic agents and methods of use thereof for the modulation of angiogenesis |
| 06/16/2005 | US20050130902 Upregulate expression of a gene encoding an antioxidative anzyme, such as superoxide dismutase or catalase; neurodegenerative, cardiovascular, cerebral, disorders, trauma, injuries, burns, cancer |
| 06/16/2005 | US20050130901 Having antimicrobial activity |
| 06/16/2005 | US20050130899 Tumor antigens |
| 06/16/2005 | US20050130898 Carboxypeptidase R inhibiting peptide |
| 06/16/2005 | US20050130884 Pharmacologically active antiviral peptides and methods of their use |
| 06/16/2005 | US20050130883 Serine protease inhibitors |
| 06/16/2005 | US20050130881 Single amino acid based compounds for counteracting effects of reactive oxygen species and free radicals |
| 06/16/2005 | US20050129617 Contacting a T lymphocyte from the patient with a diagnostic epitope of an amino acid string including hydrophilic amino acids and one of Leucine, Methionine, Isoleucine, Phenylalanine, Alanine, Glycine, Valine, or Tryptophan |
| 06/16/2005 | CA2548135A1 Synthetic hla binding peptide analogues and uses thereof |
| 06/16/2005 | CA2544888A1 Rgd targeting moiety its production and use |
| 06/15/2005 | EP1541676A1 Antibodies to fragment F1+2 of prothrombin, their production and use |
| 06/15/2005 | EP1541585A1 Cxcr4 antagonist and use thereof |
| 06/15/2005 | EP1541584A1 A group of novel synthetic antibiotic peptides |
| 06/15/2005 | EP1541583A1 Non-t cell binding peptides and their uses |
| 06/15/2005 | EP1541173A1 Method of degrading transcriptional factors of saccharometabolism-associated gene, method of inhibiting the degradation and degradation inhibitor |
| 06/15/2005 | EP1541166A1 Preventing cell death using segments of neural thread proteins |
| 06/15/2005 | EP1539956A2 GEF-H1b: BIOMARKERS, COMPLEXES, ASSAYS AND THERAPEUTIC USES THEREOF |
| 06/15/2005 | EP1539804A2 Synthesis and characterization of novel systems for guidance and vectorization of molecules of therapeutic interest towards target cells |
| 06/15/2005 | EP1539803A2 Fluoro-alkyl-cyclopeptide derivatives having anti-integrin activity |
| 06/15/2005 | EP1539236A2 Compositions, methods and kits relating to anti-platelet autoantibodies and inhibitors thereof |
| 06/15/2005 | EP1539214A2 Thrombin peptide derivatives |
| 06/15/2005 | EP1309625B1 Therapeutic compounds for ovarian cancer |
| 06/15/2005 | EP1268519B1 Inhibitors of serine proteases, particularly hepatitis c virus ns3 protease |
| 06/15/2005 | EP1075270B1 Short peptide for treatment of neurological degenerative diseases |
| 06/15/2005 | EP1001979B1 Cyclic azapeptides with angiogenic effect |
| 06/15/2005 | EP0914344B1 ASSAY AND REAGENTS FOR QUANTIFYING hBNP |
| 06/15/2005 | CN1628316A Method and system to build optimal models of 3-D molecular structures |
| 06/15/2005 | CN1626549A Carbowax alcoholized ramification of TimopEntin, combination of medication and application |
| 06/15/2005 | CN1206343C Pseudomycin production by i(pseudomonas syringae) |
| 06/15/2005 | CN1206239C Cyclohexapeptides and their mixtures, process for preparing them, and their use |